Cargos activos de Yannick Jacques
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
Cytune Pharma SAS
 Cytune Pharma SAS Miscellaneous Commercial ServicesCommercial Services Cytune Pharma SAS develops and manufactures immunotherapeutic agents for the treatment of cancer. It offers CYP 0150 produced by recombinant technology adapted to pharmaceutical processes and is the result of a single translation. The company was founded by David Béchard and Yannick Jacques on November 15, 2007 and is headquartered in Nantes, France. | Director Técnico/Científico/I+D | 15/11/2007 | - |
| Fundador | 15/11/2007 | - |
Historial de carrera de Yannick Jacques
Antiguos cargos conocidos de Yannick Jacques.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| University of Nantes | Corporate Officer/Principal | - | - |
Estadísticas
Internacional
| Francia | 3 |
Operativa
| Chief Tech/Sci/R&D Officer | 1 |
| Founder | 1 |
| Corporate Officer/Principal | 1 |
Sectorial
| Commercial Services | 2 |
| Consumer Services | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas privadas | 1 |
|---|---|
Cytune Pharma SAS
Cytune Pharma SAS Miscellaneous Commercial ServicesCommercial Services Cytune Pharma SAS develops and manufactures immunotherapeutic agents for the treatment of cancer. It offers CYP 0150 produced by recombinant technology adapted to pharmaceutical processes and is the result of a single translation. The company was founded by David Béchard and Yannick Jacques on November 15, 2007 and is headquartered in Nantes, France. | Commercial Services |
- Bolsa de valores
- Insiders
- Yannick Jacques
- Experiencia
